In November 2023, the U.S Food and Drug Administration (FDA) approved Zepbound (tirzepatide), an injectable prescription ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Zepbound (tirzepatide) is an injectable drug for weight loss in those with obesity or those with ...

Among these, the prescription drugs Zepbound and Ozempic have risen in popularity. Both are used to manage obesity and related conditions. Zepbound and Ozempic have gained attention for their ...

The makers of Zepbound, one of the most popular new brands of weight loss injectables on the market, are offering a massive price cut — if you're willing to purchase and dose your syringes out ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

If anything, the four-week supply of the 2.5 mg Zepbound single-dose vial at $399 (self-pay) is not too far from HIMS' compounded GLP-1 injectables from $199 monthly (based on a 12-month plan).

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA). The FDA updated its drug shortage ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and Zepbound has filed a lawsuit against the Food and Drug Administration ...

“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...